Combination Chemotherapy in Treating Women With Resected Breast Cancer - Related Studies

Combination Chemotherapy in Treating Women With Resected Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00033683. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer

2	Additional conditions recognized in this trial
		Breast Neoplasms

3	More general conditions related to this trial
		Breast Diseases
		Neoplasms
		Neoplasms by Site
		Skin Diseases

4	Interventions listed in this trial
		cyclophosphamide
		docetaxel
		epirubicin hydrochloride
		fluorouracil
		methotrexate
		tamoxifen citrate
		adjuvant therapy
		radiation therapy

5	Additional drug interventions recognized in this trial
		Epirubicin
		Tamoxifen

6	More general drug interventions related to this trial
		Abortifacient Agents
		Abortifacient Agents, Nonsteroidal
		Alkylating Agents
		Antibiotics, Antineoplastic
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antineoplastic Agents, Hormonal
		Antirheumatic Agents
		Bone Density Conservation Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Estrogen Antagonists
		Estrogen Receptor Modulators
		Folic Acid Antagonists
		Hormone Antagonists
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Nucleic Acid Synthesis Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Selective Estrogen Receptor Modulators
		Therapeutic Uses

7	Sponsors listed in this trial
		Institute of Cancer Research - London